The Hidden Toll of Drug Price Controls: Fewer New Treatments and Higher Medical Costs for the World
Breakup with Biogen on orelabrutinib for the treatment of autoimmune diseases
Considerations for the use of anthelminthic therapy for the treatment of neurocysticercosis
Technical consultation to assess evidence on community-based delivery of intermittent preventive treatment in pregnancy for malaria
The rising tide of climate finance - scope to adjust prudential treatment
公众号
小程序
社群
公众号小程序社群